| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.419 | 11.223 | 10.519 | 10.708 | 5.309 | 5.032 | 581 | 0 | 0 | 0 |
| Total Income - EUR | 11.422 | 11.223 | 10.519 | 10.708 | 5.309 | 5.032 | 581 | 0 | 0 | 0 |
| Total Expenses - EUR | 7.730 | 7.880 | 7.814 | 8.681 | 10.321 | 8.265 | 6.464 | 3.343 | 4.709 | 5.490 |
| Gross Profit/Loss - EUR | 3.691 | 3.344 | 2.704 | 2.027 | -5.012 | -3.233 | -5.883 | -3.343 | -4.709 | -5.490 |
| Net Profit/Loss - EUR | 3.348 | 3.113 | 2.599 | 1.920 | -5.065 | -3.281 | -5.888 | -3.343 | -4.709 | -5.490 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Vasprim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 903 | 772 | 643 | 533 | 501 | 360 |
| Current Assets | 223 | 1.183 | 540 | 1.290 | 1.525 | 1.247 | 1.434 | 1.761 | 2.701 | 3.722 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2 | 0 | 0 | 0 | 756 | 990 | 1.390 | 1.732 | 2.192 | 3.648 |
| Cash | 221 | 1.183 | 540 | 1.290 | 769 | 257 | 44 | 29 | 509 | 74 |
| Shareholders Funds | -7.294 | -4.106 | -1.438 | 508 | -4.566 | -7.760 | -13.477 | -16.861 | -21.519 | -26.889 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.517 | 5.289 | 1.977 | 782 | 6.995 | 9.779 | 15.553 | 19.198 | 24.734 | 31.004 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4781 - 4781" | |||||||||
| CAEN Financial Year |
4781
|
|||||||||
Comments - Vasprim Srl